Latest Financial Outlook News

Renergen Limited forecasts a significant increase in its loss per share for the six months ending August 2025, driven by one-off transaction expenses and full commissioning costs of its Phase 1 plant.

Vection Technologies has landed a $22.3 million multi-year framework agreement with a NATO-approved European defence partner, boosting its defence program value to $40 million through 2030.

Elanor Commercial Property Fund has reaffirmed its FY26 distribution guidance while urging securityholders to reject a takeover offer it deems undervalued and opportunistic.

Aguia Resources has updated its economic study for the Tres Estrades Rock Phosphate Project, reflecting a significant uplift in phosphate pricing and expanded production capacity that together enhance the project's financial outlook.

AMP has reached settlement agreements with several insurers over claims related to historical remediation programs, recovering approximately A$44 million to date while negotiations continue with others.

Strata Investment Holdings PLC disputes a termination notice from 1000433639 Ontario Inc. regarding a binding letter agreement and is considering legal proceedings to enforce the deal or seek damages.

Theta Gold Mines appoints Hansjoerg Plaggemars as non-executive director and promotes Bill Richie Yang to executive director, bolstering financial and project development leadership as the TGME Gold Mine Project advances.

PolarX Limited's trading suspension has been lifted immediately following its announcement of a new capital raising, signaling renewed market activity for the mining explorer.

Cullen Resources Limited has completed the sale of its Wyloo iron ore royalty to Vox Royalty Corp for A$1.5 million in cash, while retaining a future payment right tied to mining commencement.

QuickFee Limited has divested its US Pay Now payments business for US$26.35 million while keeping its US Finance operations and loan book, withdrawing FY26 earnings guidance amid ongoing tax and transaction cost assessments.

Compumedics has secured FDA clearance for its single-use Somfit®D device, effectively doubling its addressable U.S. home sleep testing market to an estimated US$240 million annually. This milestone positions the company to capture significant market share with a dual-platform EEG-based solution.

Amaero Ltd has updated its FY2026 financial guidance, forecasting revenue between A$30 million and A$35 million; a staggering 800%-900% increase year-over-year; and announced a A$50 million capital raise to expand production capacity and reduce costs.